NexGard PLUS 150 mg / 0.72 mg / 300 mg for dogs 66.1-132 lbs Chewable Tablet
RxNorm 2642691
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2642691 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: NexGard PLUS 150 mg / 0.72 mg / 300 mg for dogs 66.1-132 lbs Chewable Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Afoxolaner 150 mg / moxidectin 0.72 mg / pyrantel pamoate 300 mg Chewable Tablet [NexGard Plus]
(Atom ID: 12822906)
SY
Synonym (SY):
NexGard Plus (afoxolaner 150 mg / moxidectin 0.72 mg / pyrantel pamoate 300 mg) Chewable Tablet
(Atom ID: 12822907)
PSN